About Us

Precision Vaccinations Overview

Precision Vaccinations LLC (PVax) is an international publisher of trustworthy digital resources that empower people to make more informed vaccine decisions. PVax's innovative publishing model—an enhanced Wiki for Vaccines—translates clinical information into a language people can understand.

PVax's goal is to enable more robust conversations between healthcare providers and patients to reduce the under-use, over-use, and misuse of vaccines. Our research-based information is reviewed by doctors, nurses, and pharmacists.

'In the age of AI-produced content and biased search results, we believe vaccine science is not subjective, and trusted healthcare providers should always verify vaccine information before advising patients,' writes Donald Hackett, PVax publisher. 'This philosophy empowers healthier lives.'

PVax Mission Statement

PVax publishes vaccine information that empowers people to live life to the fullest.

Virology

Since the Human Genome Project's success in 2000, people have become aware of their genetic makeup and ways to enhance their quality of life.  However, the American Press Institute states that about 40% of people read news articles beyond headlines or lead paragraphs. The World Health Organization has confirmed vaccine misinformation is a significant threat to global health that could reverse decades of progress in reducing disease. 

Over decades, the U.S. FDA's position on virology has evolved from preventing disease to empowering human immune systems to produce protection from disease. Leaders of the FDA wrote in 2024 that the best way to counter the current large volume of vaccine misinformation is to dilute it with large amounts of truthful, accessible scientific evidence. On February 15, 2024, the FDA's Dr. Peter Marks informed the U.S. House Committee, ''Vaccines are one of the most highly effective public health interventions, responsible for saving millions of lives each year.' Marks, Director of the Center for Biologics Evaluation and Research, said no vaccine is 100% safe for all people.

According to the U.S. CDC, almost 3.5 billion vaccine doses have been distributed in the United States over the past ten years. In 2023, because of recent legislative changes, pharmacists administered more vaccines than any other healthcare provider. Research says that for every $1 spent on vaccines, $3 in indirect benefits are realized. Adult vaccination can, on average, return up to 19 times the amount spent through health and wider socio-economic benefits.

Virology's Future

PVax believes the vaccine industry needs more phase 4 clinical trials to better understand real-world results, additional co-administration phase 3 studies to ensure the efficacy of complex vaccination schedules, and expanded off-label use for diseases such as bladder cancer, gonorrhea, and diabetes. 

Vaccine Development's Future

The promise of personalized vaccines, led by the Precision Vaccines Program, which is discovering and developing the next generation of vaccines tailored to sub-populations, may disrupt the one-size-fits-all vaccination model. In 2023, clinical trials began rapidly integrating artificial intelligence and Machine Learning models to rapidly advance vaccine development. From a size of market perspective, the global clinical trials market was evaluated at $51 billion in 2023 and is expected to reach around $80 billion by 2032.

There is a growing demand for vaccines worldwide, and the market is projected by Statista to reach a revenue of $57 billion by 2024. It is forcasted to expand at an annual growth rate of 5.36%, resulting in a market volume of $70 billion by 2028. In global comparison, the U.S. is anticipated to generate the highest revenue in the vaccine market. 

Vaccine Interactions, Informed Consent, Package Inserts

This link helps explain Drug / Vaccine interactions, Informed Consent, and U.S. FDA Package Inserts.

Vaccine Information Publishing

Editorial Standards have been refined over 20 years and are committed to publishing accurate information. We stand by the Editorial Independence as our Medical Advisory Team works closely with pharmacists, doctors, and nurses across various specialty areas to ensure PVax's published content is accurate, actionable, and understandable. Visit this PVax page to access PVax's complete publishing disclosures.

Policies

Various PVax policies are listed on this webpage.

Business Overview

PVax ownership and revenues are discussed at this link.

Comments and Concerns

We believe that public feedback is not a one-way street. Instead, we are committed to engaging with you and acting based on your suggestions and other feedback. We are committed to providing greater transparency about how news is produced and offering regular contact and interaction points. We will respond to your request ASAP. Would you mind sending an email to [email protected].

Thank you,

Karen Hackett, Founder & President